In 2011, Dermarex has started a new Division “Mikku n’ Yokko” to provide more options to Dermatologist in the form of Tablets with 5 Products. This is our first Venture in Oral Segment started with newly recruited Field force. Market has responded for the new Division very positively.

Because of the positive response from the market, the company has added 3 more products and increased the strength of the Field force in more areas which covers almost the states in South India and has become a successful division.

Once again we have proved that our strategies are working very well.

Growth-wise, Mikku n’ Yokko is competing with Dermarex.

Through Mikku n’ Yokko we wants to Penetrate into the big market with more segments to increase the volume of valid Customers.

Exports Division:

Dermarex has started exports primarily to emerging markets such as Africa, Middle East, Sri Lanka and CIS countries, to provide hi-end pharmaceutical formulations, bulk drug production and supply generic drugs.   With US accredited manufacturing facilities and timely supply, we are poised to supply Soaps, Tablets, Lotion, Shampoo, Ointment, Cream and Gel according to the Different Standards, at any quantity at given time.

Rapidly escalating manufacturing expenditures and competition in developed countries, compelling pharmaceutical companies to outsource various services to inexpensive but highly skilled destinations like India. Indian Pharmaceutical Exports targeted to touch $ 25 billion by 2013-14.  With India’s aggressive brand India marketing push; it is expected to reach about $ 74 billion.

Dermarex with its specialized products and wisdom, foresee a high growth area, to supply high quality drugs at bulk quantity as well as own generic products into the emerging markets.